Paul Perco
Department of Internal Medicine IV
Medical University Innsbruck
Paul Perco is a Computational Biologist at the Department of Internal Medicine IV, Medical University of Innsbruck, Austria. He received his PhD in Microbiology and Genetics from the University of Vienna and completed his habilitation in Bioinformatics at the Medical University of Innsbruck in 2019.
His main research focus is the development and application of data integration workflows to analyze high-throughput Omics data and to subsequently model disease processes and drug mechanism of action. Aim is the identification of biomarkers and drug targets for age-related chronic kidney and cardiovascular diseases as well as for selected tumor entities.
Effect of tissue fixatives on telomere length determination by quantitative PCR.
Mechanisms of ageing and development Dec, 2005 | Pubmed ID: 16182339
Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation.
Aging cell Aug, 2008 | Pubmed ID: 18462273
Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease.
Laboratory investigation; a journal of technical methods and pathology Mar, 2009 | Pubmed ID: 19139726
Increased renal versican expression is associated with progression of chronic kidney disease.
PloS one , 2012 | Pubmed ID: 23024773
A 3-biomarker-panel predicts renal outcome in patients with proteinuric renal diseases.
BMC medical genomics Dec, 2014 | Pubmed ID: 25540021
Renal microRNA- and RNA-profiles in progressive chronic kidney disease.
European journal of clinical investigation Mar, 2016 | Pubmed ID: 26707063
Metallothioneins and renal ageing.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Sep, 2016 | Pubmed ID: 26908771
Proteomic-Biostatistic Integrated Approach for Finding the Underlying Molecular Determinants of Hypertension in Human Plasma.
Hypertension (Dallas, Tex. : 1979) 08, 2017 | Pubmed ID: 28652472
Molecular, histological, and clinical phenotyping of diabetic nephropathy: valuable complementary information?
Kidney international 02, 2018 | Pubmed ID: 29389397
Validation of systems biology derived molecular markers of renal donor organ status associated with long term allograft function.
Scientific reports 05, 2018 | Pubmed ID: 29725116
Multimarker Panels in Diabetic Kidney Disease: The Way to Improved Clinical Trial Design and Clinical Practice?
Kidney international reports Feb, 2019 | Pubmed ID: 30775618
Identification of dicarbonyl and L-xylulose reductase as a therapeutic target in human chronic kidney disease.
JCI insight 06, 2019 | Pubmed ID: 31217356
Computational Drug Screening Identifies Compounds Targeting Renal Age-associated Molecular Profiles.
Computational and structural biotechnology journal , 2019 | Pubmed ID: 31316728
Predictive Biomarkers in Nephrology Around the Corner.
Kidney international reports Jan, 2020 | Pubmed ID: 31930209
Is There Decreasing Public Interest in Renal Transplantation? A Google Trends Analysis.
Journal of clinical medicine Apr, 2020 | Pubmed ID: 32272783
Association of the COVID-19 pandemic with Internet Search Volumes: A Google Trends Analysis.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases Jun, 2020 | Pubmed ID: 32305520
Extracellular matrix protein signature of recurrent spontaneous cervical artery dissection.
Neurology 10, 2020 | Pubmed ID: 32887783
Non-adherence to antidiabetic and cardiovascular drugs in type 2 diabetes mellitus and its association with renal and cardiovascular outcomes: A narrative review.
Journal of diabetes and its complications Apr, 2021 | Pubmed ID: 33965338
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved